RENAL MEDULLARY CARCINOMA

Clinical trials for RENAL MEDULLARY CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RENAL MEDULLARY CARCINOMA trials appear

Sign up with your email to follow new studies for RENAL MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New hope for rare kidney cancer: dual immunotherapy trial seeks better control

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs, nivolumab and relatlimab, can help control advanced renal medullary carcinoma (RMC), a rare and aggressive type of kidney cancer. The trial will enroll about 30 adults whose cancer has spread or cannot be rem…

Matched conditions: RENAL MEDULLARY CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

RENAL MEDULLARY CARCINOMA

Get alerted when new RENAL MEDULLARY CARCINOMA trials appear

New hope for rare kidney cancer: dual immunotherapy trial seeks better control